- Home
- TSHA vs IMOS Comparison
TSHA vs IMOS Comparison
Compare TSHA & IMOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSHA
- IMOS
- Stock Information
- Founded
- TSHA 2019
- IMOS 1997
- Country
- TSHA United States
- IMOS Taiwan
- Employees
- TSHA N/A
- IMOS N/A
- Industry
- TSHA Biotechnology: Pharmaceutical Preparations
- IMOS Semiconductors
- Sector
- TSHA Health Care
- IMOS Technology
- Exchange
- TSHA Nasdaq
- IMOS Nasdaq
- Market Cap
- TSHA 1.2B
- IMOS 980.5M
- IPO Year
- TSHA 2020
- IMOS N/A
- Fundamental
- Price
- TSHA $4.87
- IMOS $26.90
- Analyst Decision
- TSHA Strong Buy
- IMOS
- Analyst Count
- TSHA 9
- IMOS 0
- Target Price
- TSHA $10.22
- IMOS N/A
- AVG Volume (30 Days)
- TSHA 3.9M
- IMOS 24.9K
- Earning Date
- TSHA 11-04-2025
- IMOS 11-11-2025
- Dividend Yield
- TSHA N/A
- IMOS 2.37%
- EPS Growth
- TSHA N/A
- IMOS N/A
- EPS
- TSHA N/A
- IMOS 0.01
- Revenue
- TSHA $6,310,000.00
- IMOS $748,307,671.00
- Revenue This Year
- TSHA N/A
- IMOS $3.76
- Revenue Next Year
- TSHA N/A
- IMOS $5.93
- P/E Ratio
- TSHA N/A
- IMOS $128.51
- Revenue Growth
- TSHA N/A
- IMOS N/A
- 52 Week Low
- TSHA $1.05
- IMOS $12.78
- 52 Week High
- TSHA $5.51
- IMOS $30.98
- Technical
- Relative Strength Index (RSI)
- TSHA 62.34
- IMOS 58.30
- Support Level
- TSHA $3.92
- IMOS $27.20
- Resistance Level
- TSHA $4.34
- IMOS $30.00
- Average True Range (ATR)
- TSHA 0.30
- IMOS 1.07
- MACD
- TSHA 0.06
- IMOS -0.02
- Stochastic Oscillator
- TSHA 98.33
- IMOS 59.60
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About IMOS ChipMOS TECHNOLOGIES INC.
ChipMOS TECHNOLOGIES Inc is engaged in the research, development, manufacturing, and sale of high-integration and high-precision integrated circuits and related assembly and testing services. The company's segments include Testing, Assembly, Testing, and Assembly for LCD, OLED, and other Display Panel Driver Semiconductors (LCDD), Bumping, and others. It derives a majority of its revenue from Taiwan followed by Japan, the People's Republic of China, Singapore, and others.